Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

SUMMARY: BACKGROUND: The use of opioid analgesics for patients with chronic nonmalignant pain is becoming more widely accepted, and long-acting formulations are an important treatment option. AIM: To assess conversion to extended-release OROS® hydromorphone from previous stable opioid agonist therap...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wallace, M, Rauck, R L, Moulin, D, Thipphawong, J, Khanna, S, Tudor, I C
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2007
Témata:
Original Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2040191/
https://ncbi.nlm.nih.gov/pubmed/17877652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-1241.2007.01500.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky